| Mindset Intervention for Nicotine Dependence (NCT03174730) | Fred Hutchinson Cancer Center | 2017-05-26 |
| Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer (NCT03049397) | Fred Hutchinson Cancer Center | 2017-04-05 |
| Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder (NCT02750904) | Fred Hutchinson Cancer Center | 2017-04-03 |
| Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome (NCT02943668) | Fred Hutchinson Cancer Center | 2017-03-02 |
| Communicating Health Information and Improving Coordination With Primary Care (NCT03104543) | Fred Hutchinson Cancer Center | 2017-03-01 |
| Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies (NCT02483000) | Fred Hutchinson Cancer Center | 2017-02-01 |
| Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT02888665) | Fred Hutchinson Cancer Center | 2016-12-05 |
| Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS (NCT02921061) | Fred Hutchinson Cancer Center | 2016-11-17 |
| JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02706405) | Fred Hutchinson Cancer Center | 2016-11-15 |
| Engaging School and Family in Navajo Gardening for Health (NCT03775889) | Fred Hutchinson Cancer Center | 2016-10-21 |
| HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection (NCT02343666) | Fred Hutchinson Cancer Center | 2016-08-15 |
| Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma (NCT02378922) | Fred Hutchinson Cancer Center | 2016-06-22 |
| Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer (NCT02454517) | Fred Hutchinson Cancer Center | 2016-05-19 |
| Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors (NCT02662335) | Fred Hutchinson Cancer Center | 2016-05-01 |
| The Vaginal Health Trial (NCT02516202) | Fred Hutchinson Cancer Center | 2016-04-01 |
| Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise) (NCT02982759) | Fred Hutchinson Cancer Center | 2016-04-01 |
| Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies (NCT02706392) | Fred Hutchinson Cancer Center | 2016-03-16 |
| Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant (NCT02662296) | Fred Hutchinson Cancer Center | 2016-03-01 |
| Support Group Program in Improving Quality of Life in Underserved Urban Latina Breast Cancer Survivors (NCT02521961) | Fred Hutchinson Cancer Center | 2016-02-03 |
| Tocilizumab for Chronic Graft-versus-Host Disease Treatment (NCT02174263) | Fred Hutchinson Cancer Center | 2016-02-01 |
| Hypnotherapy in Treating Chronic Pain in Cancer Survivors (NCT02637297) | Fred Hutchinson Cancer Center | 2016-01-08 |
| The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) (NCT02663544) | Fred Hutchinson Cancer Center | 2016-01-01 |
| Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT02619682) | Fred Hutchinson Cancer Center | 2015-12-30 |
| Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease (NCT02513498) | Fred Hutchinson Cancer Center | 2015-12-08 |
| Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease (NCT02491359) | Fred Hutchinson Cancer Center | 2015-11-12 |
| Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma (NCT02584829) | Fred Hutchinson Cancer Center | 2015-11-06 |
| Telephone-Delivered Interventions for Smoking Cessation (NCT02421991) | Fred Hutchinson Cancer Center | 2015-11-02 |
| HSV529 Vaccine in HSV-2 Seropositive Adults (NCT02571166) | Fred Hutchinson Cancer Center | 2015-11-01 |
| Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda (NCT02316444) | Fred Hutchinson Cancer Center | 2015-11-01 |
| Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors (NCT02192333) | Fred Hutchinson Cancer Center | 2015-08-03 |
| Diet and Metabolic Inflammation (NCT02539355) | Fred Hutchinson Cancer Center | 2015-08-01 |
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
| Women's Health Initiative Strong and Healthy Study (NCT02425345) | Fred Hutchinson Cancer Center | 2015-04-02 |
| theFRESHstudy: FRequency of Eating and Its Influence on Satiety and Health (NCT02392897) | Fred Hutchinson Cancer Center | 2015-04-01 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD (NCT02220985) | Fred Hutchinson Cancer Center | 2015-03-23 |
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (NCT01769911) | Fred Hutchinson Cancer Center | 2015-02-01 |
| Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy (NCT02226497) | Fred Hutchinson Cancer Center | 2015-01-09 |
| NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy (NCT02319824) | Fred Hutchinson Cancer Center | 2015-01-01 |
| TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery (NCT02180698) | Fred Hutchinson Cancer Center | 2014-11-17 |
| Blood Samples to Identify Biomarkers of Busulfan (NCT02291965) | Fred Hutchinson Cancer Center | 2014-11-01 |
| SmartQuit Program for Smoking Cessation (NCT04510077) | Fred Hutchinson Cancer Center | 2014-10-22 |
| JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis (NCT02251821) | Fred Hutchinson Cancer Center | 2014-10-20 |
| Cancer Communication Within Hispanic Social Networks (NCT04444232) | Fred Hutchinson Cancer Center | 2014-09-09 |
| TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors (NCT02466061) | Fred Hutchinson Cancer Center | 2014-07-01 |
| NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT02059850) | Fred Hutchinson Cancer Center | 2014-07-01 |
| Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder (NCT01377168) | Fred Hutchinson Cancer Center | 2014-05-01 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children (NCT01858740) | Fred Hutchinson Cancer Center | 2014-04-10 |
| Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit) (NCT01812278) | Fred Hutchinson Cancer Center | 2014-03-24 |
| Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT02044796) | Fred Hutchinson Cancer Center | 2014-01-23 |
| MsFLASH-04: Pilot Trial: Telephone Behavioral Therapy for Menopause-related Sleep Disturbance (NCT01936441) | Fred Hutchinson Cancer Center | 2013-11-01 |
| Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01894477) | Fred Hutchinson Cancer Center | 2013-11-01 |
| Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (NCT01523821) | Fred Hutchinson Cancer Center | 2013-10-11 |
| Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies (NCT01921387) | Fred Hutchinson Cancer Center | 2013-10-09 |
| Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma (NCT01957709) | Fred Hutchinson Cancer Center | 2013-09-25 |
| Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma (NCT01961115) | Fred Hutchinson Cancer Center | 2013-09-13 |
| CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT01881867) | Fred Hutchinson Cancer Center | 2013-09-10 |
| Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma (NCT01807182) | Fred Hutchinson Cancer Center | 2013-08-20 |
| Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (NCT01812252) | Fred Hutchinson Cancer Center | 2013-08-19 |
| Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients (NCT01929408) | Fred Hutchinson Cancer Center | 2013-07-19 |
| HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women (NCT01815580) | Fred Hutchinson Cancer Center | 2013-07-01 |
| Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01620229) | Fred Hutchinson Cancer Center | 2013-06-01 |
| Chronic GVHD Response Measures Validation (NCT01902576) | Fred Hutchinson Cancer Center | 2013-06-01 |
| Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia (NCT01865617) | Fred Hutchinson Cancer Center | 2013-05-22 |
| INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant (NCT01602211) | Fred Hutchinson Cancer Center | 2013-05-14 |
| Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01804101) | Fred Hutchinson Cancer Center | 2013-05-07 |
| Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT01831232) | Fred Hutchinson Cancer Center | 2013-05-01 |
| Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant (NCT01758484) | Fred Hutchinson Cancer Center | 2013-04-01 |
| Comparing Different Methods for Collection of Comorbidity Data Per the HCT-CI (NCT03434561) | Fred Hutchinson Cancer Center | 2013-03-22 |
| Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit) (NCT01812070) | Fred Hutchinson Cancer Center | 2013-03-01 |
| Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma (NCT01758458) | Fred Hutchinson Cancer Center | 2013-02-01 |
| Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT01729845) | Fred Hutchinson Cancer Center | 2012-12-20 |
| Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant (NCT01640301) | Fred Hutchinson Cancer Center | 2012-12-06 |
| Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant (NCT01236885) | Fred Hutchinson Cancer Center | 2012-12-01 |
| FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health (NCT01619020) | Fred Hutchinson Cancer Center | 2012-10-01 |
| Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life (NCT01930981) | Fred Hutchinson Cancer Center | 2012-10-01 |
| Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies (NCT01527045) | Fred Hutchinson Cancer Center | 2012-09-25 |
| Glucosamine and Chondroitin Effects (NCT01682694) | Fred Hutchinson Cancer Center | 2012-09-01 |
| Crohn's Allogeneic Transplant Study (NCT01570348) | Fred Hutchinson Cancer Center | 2012-07-17 |
| Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS (NCT01607645) | Fred Hutchinson Cancer Center | 2012-07-01 |
| Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease (NCT01616056) | Fred Hutchinson Cancer Center | 2012-06-01 |
| Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation (NCT01525407) | Fred Hutchinson Cancer Center | 2012-05-01 |
| Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant (NCT01419795) | Fred Hutchinson Cancer Center | 2012-05-01 |
| Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT01567059) | Fred Hutchinson Cancer Center | 2012-05-01 |
| CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant (NCT01475058) | Fred Hutchinson Cancer Center | 2012-04-01 |
| Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy (NCT01525420) | Fred Hutchinson Cancer Center | 2012-03-01 |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma (NCT01339663) | Fred Hutchinson Cancer Center | 2012-03-01 |
| Gene Therapy for Fanconi Anemia (NCT01331018) | Fred Hutchinson Cancer Center | 2012-02-22 |
| 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01503242) | Fred Hutchinson Cancer Center | 2012-01-09 |
| Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery (NCT01477021) | Fred Hutchinson Cancer Center | 2012-01-01 |
| Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS (NCT01300572) | Fred Hutchinson Cancer Center | 2012-01-01 |
| High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT01434472) | Fred Hutchinson Cancer Center | 2011-11-16 |
| MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms (NCT01418209) | Fred Hutchinson Cancer Center | 2011-11-01 |
| Vitamin D and Adipose Tissue Inflammation (NCT01477034) | Fred Hutchinson Cancer Center | 2011-11-01 |
| Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission (NCT01465386) | Fred Hutchinson Cancer Center | 2011-11-01 |
| Diet and Systemic Inflammation (NCT01424306) | Fred Hutchinson Cancer Center | 2011-10-01 |
| COMIDAS Comparing Original Mexican Diets and Standard US Diets (NCT01369173) | Fred Hutchinson Cancer Center | 2011-10-01 |
| Scleroderma Treatment With Autologous Transplant (STAT) Study (NCT01413100) | Fred Hutchinson Cancer Center | 2011-09-15 |
| Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies (NCT01427881) | Fred Hutchinson Cancer Center | 2011-09-01 |
| Cervical Cancer Screening Among Hispanic Women (NCT01525433) | Fred Hutchinson Cancer Center | 2011-09-01 |
| PATH Partnering to Achieve Tobacco-free Health (NCT01533974) | Fred Hutchinson Cancer Center | 2011-06-01 |